Fed-batch induction collapse in a high-cell-density E. coli scFv process
A 10 L fed-batch bioreactor runs E. coli BL21(DE3) carrying a pET plasmid that expresses a periplasmic scFv. Glycerol is fed exponentially to hold a specific growth rate of 0.30 h⁻¹ at 37 °C and pH 7.0, with dissolved oxygen controlled at 30% by cascading agitation and aeration. Induction with 1 mM IPTG is performed at OD600 = 55. Immediately after induction the oxygen uptake rate falls by 40%, dissolved oxygen oscillates despite maximum aeration, and acetate rises to 9 g/L within 3 h. Eight hours post-induction the biomass is high but soluble scFv is only 0.4 g/L against a 5 g/L target; SDS-PAGE of the pellet shows a dominant band at the expected molecular weight. Plasmid retention determined by replica plating is 62%. The team proposes doubling the feed rate to finish the run sooner and raising IPTG to 2 mM.
1. Separate the observations that are engineering consequences of the feeding and induction design from those that point to the construct or host, and justify each assignment.
Read the worked answer
Engineering consequences. (i) Acetate at 9 g/L is the signature of overflow metabolism: at μ = 0.30 h⁻¹ with a glycerol feed and a falling oxygen supply, flux through glycolysis exceeds TCA cycle capacity, so carbon spills to acetate. (ii) The post-induction DO oscillation at maximum agitation and aeration means the oxygen transfer rate has hit the vessel ceiling (kLa-limited), not that the cells suddenly need less oxygen; the 40% fall in OUR reflects metabolic burden and slower growth, but the controller still cannot keep up. (iii) Induction at OD600 = 55 is a very high cell density for a pET/T7 system, so the volumetric demand for O2 and the plasmid copy-number burden are both maximal at the moment of induction.
Construct/host-related candidates. The strong insoluble band at the correct molecular weight indicates aggregation, most plausibly folding kinetics outrun by synthesis at 37 °C, not a truncated or out-of-frame product (which would give a wrong-size or absent band). Plasmid retention of 62% is real and costs yield, but 38% loss alone cannot explain 0.4 versus 5 g/L, so it is a contributing, not primary, cause.
Verdict. Most of the failure is process design: high-μ growth to a high OD, induction at 37 °C, and an oxygen-limited vessel. The proposal to double the feed and IPTG makes every one of these worse.
2. Redesign the induction phase with explicit setpoints and predict which measured variables would change and in which direction.
Read the worked answer
Pre-induction. Reduce the exponential feed to μ = 0.10–0.12 h⁻¹ and let acetate fall below 2 g/L before inducing; this keeps the TCA capacity ahead of glycolytic flux and lowers the O2 demand per gram of biomass.
Induction point. Induce at OD600 = 20–30 rather than 55, so the culture still has headroom in kLa for the post-induction burden. Use 0.1–0.5 mM IPTG: the T7 system is already saturated near 0.1 mM, so 2 mM adds burden and cost without adding product.
Temperature. Shift to 25–28 °C at induction and hold it. Lower temperature slows translation relative to folding and is the single most reliable lever against periplasmic inclusion bodies.
Oxygen and feed. Keep DO at 30% with enriched (or pure) O2 sparging if the vessel cannot otherwise meet demand, and switch to a DO-stat or acetate-controlled feed rather than a fixed exponential profile.
Predicted changes. Acetate should stay below 2 g/L, the DO oscillation should stop, growth rate should fall to 0.1–0.15 h⁻¹, and the soluble:insoluble ratio on SDS-PAGE should shift toward soluble. Volumetric productivity per litre per hour may initially drop, but product per gram of biomass should rise; the trade should be evaluated on soluble g/L, not OD.
3. Design one experiment that distinguishes plasmid loss from inclusion-body formation as the cause of low soluble titer, and state the expected result under each hypothesis.
Read the worked answer
Design. Grow a single culture to the induction point under the improved pre-induction conditions, then split it into two identical bioreactors or shake flasks: one induced at 37 °C, one at 25 °C, both with 0.1 mM IPTG and the same medium. At 2, 4, 6 and 8 h, take samples and measure three things on each: (1) colony-forming units on plates with and without antibiotic, to give the fraction of plasmid-bearing cells; (2) the same fraction by quantitative PCR of plasmid versus chromosomal targets, which also detects plasmid-bearing but non-expressing cells; (3) soluble and insoluble scFv by SDS-PAGE or densitometry after sonication and centrifugation.
Interpretation. If plasmid loss dominates, the plasmid-bearing fraction should fall in parallel with the fall in specific product, and the 25 °C arm should show the same loss but the same product per plasmid-bearing cell; the insoluble fraction should be minor. If inclusion-body formation dominates, plasmid retention should be similar in both arms, but the 37 °C arm should give a large insoluble band and the 25 °C arm a comparable total band that is mostly soluble.
Refinement. Include an uninduced control to define the basal band and a plasmid-free host control to confirm band identity. Normalising product to plasmid-bearing cells is the key step; bulk titer confounds the two hypotheses.